LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $784,057 | -5.7% | 16,260 | -2.3% | 0.02% | -19.4% |
| Q4 2022 | $831,218 | +24.8% | 16,651 | -1.7% | 0.03% | +40.9% |
| Q3 2022 | $666,000 | -35.8% | 16,945 | -10.2% | 0.02% | -29.0% |
| Q2 2022 | $1,037,000 | -4.9% | 18,866 | -37.1% | 0.03% | +10.7% |
| Q1 2022 | $1,090,000 | -13.5% | 29,995 | +10.9% | 0.03% | -15.2% |
| Q4 2021 | $1,260,000 | -39.5% | 27,043 | -34.4% | 0.03% | -47.6% |
| Q3 2021 | $2,084,000 | +6.5% | 41,212 | -13.5% | 0.06% | +6.8% |
| Q2 2021 | $1,956,000 | -0.2% | 47,656 | -29.4% | 0.06% | -10.6% |
| Q1 2021 | $1,959,000 | +6.8% | 67,489 | +3.6% | 0.07% | -12.0% |
| Q4 2020 | $1,835,000 | +42.7% | 65,162 | +56.4% | 0.08% | +17.2% |
| Q3 2020 | $1,286,000 | -17.7% | 41,673 | +13.4% | 0.06% | -22.0% |
| Q2 2020 | $1,563,000 | – | 36,735 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $89,605,000 | 22.89% |
| Paradigm Biocapital Advisors LP | 978,596 | $53,823,000 | 10.73% |
| FengHe Fund Management Pte. Ltd. | 475,263 | $26,139,000 | 10.25% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,222,342 | $67,229,000 | 9.65% |
| HHLR ADVISORS, LTD. | 4,436,617 | $244,014,000 | 5.23% |
| Iron Triangle Partners LP | 495,329 | $27,243,000 | 3.53% |
| Parkman Healthcare Partners LLC | 117,807 | $6,479,000 | 2.39% |
| AtonRa Partners | 28,172 | $1,549,000 | 1.42% |
| Vivo Capital, LLC | 244,375 | $13,441,000 | 1.35% |
| Avidity Partners Management LP | 1,000,000 | $55,000,000 | 1.26% |